What Cigna Group (CI) Said on Its Q3 Earnings Call
Cigna Group (CI) reported Q3 2026 adjusted revenue of $73.8B and adjusted earnings of $2.1B, raising its full-year EPS outlook to at least $30.60. Cigna Healthcare saw 9% revenue growth, while Evernorth's revenue rose 6%. The company expects 10% EPS growth in 2027, with cost savings targeting $3B by 2030.
How this was made

The 30-second read
Why it matters
The guidance lift is a fresh, material disclosure that can drive the stock higher, especially ahead of market open.
Market read
First‑time earnings guidance raise for a large U.S. health insurer; likely bullish impact on CI and related healthcare stocks.
What to watch
Potential headwinds from ACA exchange exit and pharmacy benefit margin compression could limit upside.
Background
Cigna Group reported Q3 2026 results, highlighted revenue growth, and announced higher full‑year earnings guidance for both its core insurance and Evernorth businesses.
Ticker impact
Cigna Group raised its full-year adjusted earnings outlook to at least $30.60 per share and increased its Evernorth earnings guidance, providing fresh guidance numbers not previously disclosed.
likely upward pressure as the market prices in higher earnings expectations
The new earnings per share target and higher Evernorth outlook are material, first‑time disclosed figures that can move the share price.
Market effects
Positive for health insurance and PBM sector, may lift peers like UnitedHealth (UNH) and Anthem (ELV).
U.S. market may see modest gains in healthcare stocks.
Limited to U.S. healthcare sector; no broad macro impact.
Counterpoint
If the guidance raise is already priced in, the stock could face a short‑term pullback.
Key entities
- companyCigna Group
U.S. health services insurer and PBM operator.

